Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2024-05-09 00:00:00 ET · period of report 2023-08-25 · accession 0001562180-24-003948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | 2023-08-25 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.15 | -27.0K | 668.8K | -4% | -$31.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-25 | S | D | 27,000 | $1.15 | 668,840 | D | — | — |